Metabotropic glutamate receptors: From the workbench to the bedside von Nicoletti, F., Bockaert, J., Collingridge, G.L., Conn, P.J., Ferraguti, F., Schoepp, D.D., Wroblewski, J.T., Pin, J.P.

Volltext

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors von Kingston, A.E, Ornstein, P.L, Wright, R.A, Johnson, B.G, Mayne, N.G, Burnett, J.P, Belagaje, R, Wu, S, Schoepp, D.D

Volltext

Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor von Linden, A.-M, Johnson, B.G, Peters, S.C, Shannon, H.E, Tian, M, Wang, Y, Yu, J.L, Köster, A, Baez, M, Schoepp, D.D

Volltext

The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits von Witkin, J.M., Monn, J.A., Schoepp, D.D., Li, X., Overshiner, C., Mitchell, S.N., Carter, G., Johnson, B., Rasmussen, K., Rorick-Kehn, L.M.

Volltext

The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity von Fitzjohn, S.M, Bortolotto, Z.A, Palmer, M.J, Doherty, A.J, Ornstein, P.L, Schoepp, D.D, Kingston, A.E, Lodge, D, Collingridge, G.L

Volltext

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors von SCHOEPP, D. D, JOHNSON, B. G, MONN, J. A, WRIGHT, R. A, SALHOFF, C. R, MAYNE, N. G, WU, S, COCKERHAM, S. L, BURNETT, J. P, BELEGAJE, R, BLEAKMAN, D

Volltext

The selective group mGlu2/3 receptor agonist LY379268 suppresses REM sleep and fast EEG in the rat von Feinberg, I, Campbell, I.G, Schoepp, D.D, Anderson, K

Volltext

Induction or protection of limbic seizures in mice by mGluR subtype selective agonists von Tizzano, J.P., Griffey, K.I., Schoepp, D.D.

Volltext

Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4- dicarboxylate von Schoepp, D D, Johnson, B G, Salhoff, C R, Valli, M J, Desai, M A, Burnett, J P, Mayne, N G, Monn, J A

Volltext

A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex von Marek, G.J, Wright, R.A, Gewirtz, J.C, Schoepp, D.D

Volltext

Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495 von Linden, A.-M., Johnson, B.G., Trokovic, Nina, Korpi, E.R., Schoepp, D.D.

Volltext

Comparison of c-Fos induction in the brain by the mGlu2/3 receptor antagonist LY341495 and agonist LY354740: Evidence for widespread endogenous tone at brain mGlu2/3 receptors in v... von Linden, A.-M., Bergeron, M., Schoepp, D.D.

Volltext

Increased c-Fos expression in the centromedial nucleus of the thalamus in metabotropic glutamate 8 receptor knockout mice following the elevated plus maze test von Linden, A.-M, Baez, M, Bergeron, M, Schoepp, D.D

Volltext

Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro von Nie, Y., Schoepp, D.D., Klaunig, J.E., Yard, M., Lahiri, D.K., Kubek, M.J.

Volltext

The Novel Metabotropic Glutamate Receptor Agonist 2 R ,4 R -APDC Potentiates Stimulation of Phosphoinositide Hydrolysis in the Rat Hippocampus by 3,5-dihydroxyphenylglycine: Eviden... von SCHOEPP, D.D, SALHOFF, C.R, WRIGHT, R.A, JOHNSON, B.G, BURNETT, J.P, MAYNE, N.G, BELAGAJE, R, WU, S, MONN, J.A

Volltext

LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats von Helton, D.R., Tizzano, J.P., Monn, J.A., Schoepp, D.D., Kallman, M.J.

Volltext

Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268 von Cartmell, J, Monn, J A, Schoepp, D D

Volltext

14. Second messenger responses in brain slices to elucidate novel glutamate receptors von Schoepp, D.D.

Volltext

P.3.027 Activity in the fear-potentiated startle (FPS) in rodents and healthy subjects with LY354740, a novel mGlu2/3 receptor agonist von Levine, L., Landbloom, R.P., Schoepp, D.D., Tizzano, J.P., Grillon, C.

Volltext

S.08.01 The metabotropic glutamate receptor progress towards novel therapeutics von Schoepp, D.D., Swanson, C., Linden, A., Levine, L., Potter, W.

Volltext